Section Arrow
AIRS.NASDAQ
- AirSculpt Technologies
Quotes are at least 15-min delayed:2026/09/15 18:21 EDT
After Hours
Last
 2.12
-0.01 (-0.47%)
Bid
2.11
Ask
2.13
High 2.13 
Low 2.1 
Volume 7.49K 
Regular Hours (Closed)
Last
 2.13
-0.25 (-10.50%)
Day High 
2.4 
Prev. Close
2.38 
1-M High
3.46 
Volume 
1.11M 
Bid
2.11
Ask
2.13
Day Low
2.1 
Open
2.4 
1-M Low
2.36 
Market Cap 
171.59M 
Currency 美元 
P/E -- 
%Yield 19.25 
10-SMA 2.53 
20-SMA 2.62 
50-SMA 3.66 
52-W High 12 
52-W Low 1.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.18/--
Enterprise Value
242.40M
Balance Sheet
Book Value Per Share
1.45
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
151.82M
Operating Revenue Per Share
2.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LFSTLifeStance Health Group13.06-0.32-2.39%102.92PE
After Hours 12.975 -0.085 -0.65%
BKDBrookdale Senior Living11.85-0.06-0.50%-- 
After Hours 11.85 0 0.00%
AVAHAveanna Healthcare Holdings14.31-0.07-0.49%11.41PE
After Hours 14.01 -0.3 -2.10%
OPCHOption Care Health23.52-0.47-1.96%18.17PE
After Hours 23.52 0 0.00%
CMPSCOMPASS Pathways Plc13.81-0.73-5.02%-- 
After Hours 13.7 -0.11 -0.80%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.